Cargando…

A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy

BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data....

Descripción completa

Detalles Bibliográficos
Autores principales: Yogodzinski, Christopher, Arab, Abolfazl, Pritchard, Justin R., Goodarzi, Hani, Gilbert, Luke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524992/
https://www.ncbi.nlm.nih.gov/pubmed/34663427
http://dx.doi.org/10.1186/s13073-021-00987-8
_version_ 1784585586132123648
author Yogodzinski, Christopher
Arab, Abolfazl
Pritchard, Justin R.
Goodarzi, Hani
Gilbert, Luke A.
author_facet Yogodzinski, Christopher
Arab, Abolfazl
Pritchard, Justin R.
Goodarzi, Hani
Gilbert, Luke A.
author_sort Yogodzinski, Christopher
collection PubMed
description BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data. RESULTS: We have developed a new data retrieval and indexing framework that allows us to integrate publicly available data from different sources and to combine publicly available data with new or bespoke datasets. Our approach, which we have named the cancer data integrator (CanDI), is straightforward to implement, is well documented, and is continuously updated which should enable individual users to take full advantage of efforts to map cancer cell biology. We show that CanDI empowered testable hypotheses of new synthetic lethal gene pairs, genes associated with sex disparity, and immunotherapy targets in cancer. CONCLUSIONS: CanDI provides a flexible approach for large-scale data integration in cancer research enabling rapid generation of hypotheses. The CanDI data integrator is available at https://github.com/GilbertLabUCSF/CanDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00987-8.
format Online
Article
Text
id pubmed-8524992
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85249922021-10-22 A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. Goodarzi, Hani Gilbert, Luke A. Genome Med Software BACKGROUND: Advances in cancer biology are increasingly dependent on integration of heterogeneous datasets. Large-scale efforts have systematically mapped many aspects of cancer cell biology; however, it remains challenging for individual scientists to effectively integrate and understand this data. RESULTS: We have developed a new data retrieval and indexing framework that allows us to integrate publicly available data from different sources and to combine publicly available data with new or bespoke datasets. Our approach, which we have named the cancer data integrator (CanDI), is straightforward to implement, is well documented, and is continuously updated which should enable individual users to take full advantage of efforts to map cancer cell biology. We show that CanDI empowered testable hypotheses of new synthetic lethal gene pairs, genes associated with sex disparity, and immunotherapy targets in cancer. CONCLUSIONS: CanDI provides a flexible approach for large-scale data integration in cancer research enabling rapid generation of hypotheses. The CanDI data integrator is available at https://github.com/GilbertLabUCSF/CanDI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00987-8. BioMed Central 2021-10-18 /pmc/articles/PMC8524992/ /pubmed/34663427 http://dx.doi.org/10.1186/s13073-021-00987-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
Yogodzinski, Christopher
Arab, Abolfazl
Pritchard, Justin R.
Goodarzi, Hani
Gilbert, Luke A.
A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title_full A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title_fullStr A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title_full_unstemmed A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title_short A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
title_sort global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524992/
https://www.ncbi.nlm.nih.gov/pubmed/34663427
http://dx.doi.org/10.1186/s13073-021-00987-8
work_keys_str_mv AT yogodzinskichristopher aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT arababolfazl aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT pritchardjustinr aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT goodarzihani aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT gilbertlukea aglobalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT yogodzinskichristopher globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT arababolfazl globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT pritchardjustinr globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT goodarzihani globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy
AT gilbertlukea globalcancerdataintegratorrevealsprinciplesofsyntheticlethalitysexdisparityandimmunotherapy